Skip to results
Modify your search
NARROW
1-20 of 35
Authors: Ioannis Parodis
Journal Article
E082 Self-efficacy as a key contributor to improved health outcomes in patients with idiopathic inflammatory myopathies
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.317, https://doi.org/10.1093/rheumatology/keaf142.317
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Unsupervised machine learning identifies distinct systemic lupus erythematosus patient endotypes with differential response to belimumab
Rheumatology, keaf215, https://doi.org/10.1093/rheumatology/keaf215
Published: 17 April 2025
Journal Article
Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials
Rheumatology, keaf145, https://doi.org/10.1093/rheumatology/keaf145
Published: 14 March 2025
Journal Article
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting
Rheumatology, keaf128, https://doi.org/10.1093/rheumatology/keaf128
Published: 03 March 2025
Journal Article
Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomized clinical trials of belimumab Get access
Rheumatology, keaf107, https://doi.org/10.1093/rheumatology/keaf107
Published: 22 February 2025
Journal Article
Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2697–2705, https://doi.org/10.1093/rheumatology/keae575
Published: 16 October 2024
Journal Article
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset
Rheumatology, Volume 64, Issue 4, April 2025, Pages 2133–2142, https://doi.org/10.1093/rheumatology/keae520
Published: 25 September 2024
Journal Article
Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity
Rheumatology, Volume 63, Issue 9, September 2024, Pages 2494–2502, https://doi.org/10.1093/rheumatology/keae216
Published: 05 April 2024
Journal Article
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Rheumatology, Volume 64, Issue 2, February 2025, Pages 597–606, https://doi.org/10.1093/rheumatology/keae128
Published: 02 March 2024
Journal Article
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up
Rheumatology, Volume 64, Issue 2, February 2025, Pages 639–647, https://doi.org/10.1093/rheumatology/keae120
Published: 24 February 2024
Journal Article
Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab
Rheumatology, Volume 64, Issue 2, February 2025, Pages 623–631, https://doi.org/10.1093/rheumatology/keae023
Published: 12 January 2024
Journal Article
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
Rheumatology, Volume 63, Issue 5, May 2024, Pages 1341–1351, https://doi.org/10.1093/rheumatology/kead382
Published: 28 July 2023
Journal Article
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study
Rheumatology, Volume 63, Issue 3, March 2024, Pages 657–664, https://doi.org/10.1093/rheumatology/kead250
Published: 25 May 2023
Journal Article
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials
Rheumatology, Volume 63, Issue 2, February 2024, Pages 338–348, https://doi.org/10.1093/rheumatology/kead253
Published: 25 May 2023
Journal Article
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab
Rheumatology, Volume 63, Issue 3, March 2024, Pages 798–808, https://doi.org/10.1093/rheumatology/kead249
Published: 25 May 2023
Journal Article
P065 Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.106, https://doi.org/10.1093/rheumatology/kead104.106
Published: 24 April 2023
Journal Article
OA29 Flares following COVID-19 vaccination in patients with idiopathic inflammatory myopathies: combined analysis from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) studies
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.029, https://doi.org/10.1093/rheumatology/kead104.029
Published: 24 April 2023
Journal Article
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Rheumatology, Volume 63, Issue 1, January 2024, Pages 127–139, https://doi.org/10.1093/rheumatology/kead180
Published: 21 April 2023
Journal Article
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
Rheumatology, Volume 62, Issue 9, September 2023, Pages e263–e268, https://doi.org/10.1093/rheumatology/kead149
Published: 02 April 2023
Journal Article
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
Rheumatology, Volume 62, Issue 12, December 2023, Pages 3838–3848, https://doi.org/10.1093/rheumatology/kead144
Published: 24 March 2023
